Azar touts Trump administration’s efforts on COVID-19 vaccine
Health and Human Services secretary dismisses Biden concerns about lack of access to data on ‘Special Report’
President Trump on Friday claimed the U.S. would not have a coronavirus vaccine on the way had he not been in the Oval Office to oversee its development.
“We’re way ahead on vaccines," Trump said during a press conference at the White House. “You wouldn’t have a vaccine if it weren’t for me for another 4 years.”
The president reasoned that the Food and Drug Administration would have never been able to do what he required them to do to speed up the process.
Through Operation Warp Speed, the Trump administration coordinated and invested in the accelerated development of a vaccine – with the ambitious goal of having 300 million doses of a safe vaccine available by January.
TRUMP TARGETS MEDICARE DRUG PRICES WITH COST-CUTTING MEASURES
Pfizer and partner BioNTech SE announced they applied for emergency authorization use on Friday, after clinical trial data showed their vaccine was 95% effective in preventing infection, with no serious safety concerns observed so far.
Moderna announced earlier this week that its vaccine candidate is just shy of 95% effective, and the company is expected to apply for emergency use authorization soon.
The promising news comes as the U.S. braces for painful months ahead amid a sharp resurgence in confirmed cases. This week, the country surpassed a grim milestone as data showed more than 254,000 Americans had fallen victim to the virus since the outbreak began.
CLICK HERE TO GET THE FOX NEWS APP
Trump made the comments as he was announcing several new cost-cutting measures designed to lower prescription drug prices.
The measures included ending rebates provided to pharmacy benefit managers, linking prices paid for drugs under Medicare to prices paid for the same drugs in other countries and ending the Unapproved Drug Initiative.
The president claimed that big pharmaceutical companies, like Pfizer, withheld the promising results from the vaccine trials until after the election because his administration was pursuing these actions to reduce drug prices, which are a detriment to big pharmaceutical companies.
Pfizer said the timing of its results had nothing to do with Election Day.
Source: Read Full Article